Aceto - About the company
Aceto is a public company based in New York City (United States), founded in 1947. It operates as a Traditional company manufacturing APIs, intermediates, formulations and chemicals. Aceto has raised an undisclosed amount in funding. The company has 370 active competitors, including 16 funded and 92 that have exited. Its top competitors include companies like Aurobindo Pharma, Aizant and Almac Group.
Company Details
Aceto is engaged in the marketing, sale and distribution of Human Health products, Pharmaceutical Ingredients, and Performance Chemicals. Human health products include finished dosage form generics and Nutritionals. Pharmaceutical ingredients include APIs and pharmaceutical intermediates. Performance chemicals include speciality chemicals and agricultural protection products.
- Website
- aceto.com
- Registered Address
- 184, 185, 186 P, BAVLA 8KM., STONE, SKHJ BVL HIGHWAY, CI. CHACHRAWADI VASNA, TA. SANAND, Sanand, Ahmedabad, Sanand, Gujarat, India, 382110
Key Metrics
Founded Year
1947
Location
New York City, United States
Stage
Public
Latest Funding Round
Investors
Ranked
99th among 370 active competitors
Employee Count
441 as on Mar 31, 2026
Investment & Acquisitions
Similar Companies
Exit Details
Public
Legal entities associated with Aceto
Aceto is associated with 1 legal entity given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Documents |
|---|---|---|---|---|
Aceto Pharma (india) Private Limited CIN: U24232GJ2007FTC142338 , India, Active | Jan 29, 2007 | $40.4M (As on Mar 31, 2025) | 28 (As on Oct 31, 2024) |
Aceto's IPO details
Aceto got listed on Jan 13, 1978.
Click here to take a look at Aceto's IPO in detail
Sign up to download Aceto's company profile
Aceto's funding and investors
Aceto has raised funding over 1 round. Aceto has 1 institutional investor.
Here is the list of recent funding rounds of Aceto:
Date of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Nov 11, 2015 | 1323506 | Post IPO | 8796718 | 9807011 | 3571652 | 9496270 |
View details of Aceto's funding rounds and investors
Aceto's founders and board of directors
Founder? Claim ProfileAceto's employee count trend
Aceto has 441 employees as of Mar 26. Here is Aceto's employee count trend over the years:
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Aceto's Competitors and alternates
Top competitors of Aceto include Aurobindo Pharma, Aizant and Almac Group. Here is the list of Top 10 competitors of Aceto, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | Aurobindo Pharma 1986, Hyderabad (India), Public | Provider of generic biocatalytic solutions | - | 61/100 | |
2nd | Company offering contract development services for small molecules | $16.8M | 59/100 | ||
3rd | Almac Group 2001, Craigavon (United Kingdom), Series D | CRAMS company offering preclinical development and CDMO services, also offering companion diagnostic development | $339M | 57/100 | |
4th | Concord Biotech 2000, Ahmedabad (India), Public | CDMO focused on manufacturing API | - | 56/100 | |
5th | Nucleus RadioPharma 2022, Rochester (United States), Series A | CDMO focused on providing of radiopharmaceuticals manufacturing and supply chain services | $72.1M | 54/100 | |
6th | Indoco Remedies 1947, Mumbai (India), Public | Provider of APIs manufacturing and formulation services | - | 54/100 | |
7th | Asymchem 1995, Morrisville (United States), Public | CDMO providing comprehensive pharmaceutical development and manufacturing solutions globally | - | 53/100 | |
8th | CDMO focused on amino acids and small molecules | - | - | 53/100 | |
9th | Development and manufacturing of niche pharmaceutical products for the generic industry | $2.74M | 52/100 | ||
10th | Wanbury Limited 1990, Mumbai (India), Public | Manufacturer of anti-diabetic drugs | - | - | 52/100 |
99th | Aceto 1947, New York City (United States), Public | Traditional company manufacturing APIs, intermediates, formulations and chemicals | - | 35/100 |
Looking for more details on Aceto's competitors? Click here to see the top ones
Aceto's Investments and acquisitions
Aceto has not made any investments yet. Aceto has made 8 acquisitions.Here is the list of latest three $acquisitions:
Filter this list
Date of Investment/Acquisition | Type | Company Name | Founded Year | Location |
|---|---|---|---|---|
Mar 02, 2022 | Acquisition | 2014 | Ogden (United States) | |
Mar 02, 2022 | Acquisition | 1979 | Centerville (United States) | |
Oct 12, 2021 | Acquisition | 2018 | Limerick (Ireland) |
See all acquisitions by Aceto
News related to Aceto
•
After M&A sprint, newly unveiled Actylis aims to be 'much more than just a distributor'Fiercepharma•Oct 18, 2022•Aceto, Actylis
•
•
Aceto Consolidates Acquisition of Six Manufacturers, Strengthening Its Unique Hybrid Model that Provides Major Supply Chain Benefits to CustomersBusiness Wire•Jan 26, 2022•Aceto, A&C, A&C Bio Buffer, Cascade Chemistry and 3 others
•
•
•
•
•
•
•
Are you a Founder ?
FAQs about Aceto
Explore our recently published companies
- Apex Acquisition - Austin based, 2020 founded, Unfunded company
- Agrivis - Gorakhpur based, 2024 founded, Unfunded company
- NearPoint - Murshidabad based, Unfunded company
- Martin - Lima based, 1996 founded, Unfunded company
- Aip - Unfunded company
- Savetzastampu - Serbia based, Funding Raised company